Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Falchi

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Birth Defects Original Article Series|January 1, 1982
Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in SardiniaA Cao, M Furbetta, R Galanello, et al.
American Journal of Human Genetics|July 1, 1981
Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in SardiniaA Cao, M Furbetta, R Galanello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial, G Ambrosini, M Balli, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Birth Defects Original Article Series|January 1, 1982
Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in SardiniaA Cao, M Furbetta, R Galanello, et al.
American Journal of Human Genetics|July 1, 1981
Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in SardiniaA Cao, M Furbetta, R Galanello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial, G Ambrosini, M Balli, et al.
Pageof 5